RF
JAZZ icon

RHS Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

RHS Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Buy
1,229
+153
+14% +$33.5K 0.12% 131
2026
Q1 		$203K Buy
+1,076
New +$188K 0.1% 141

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

RHS Financial's JAZZ Position: Q2 2026 in Review

RHS Financial increased its Jazz Pharmaceuticals (JAZZ) stake by 14% in Q2 2026, buying an estimated $33.5K and bringing the position to 1,229 shares worth $296K. The position accounts for 0.12% of the portfolio, ranked #131.

RHS Financial first reported a position in JAZZ in Q1 2026 and has held it in 2 quarters since. 396 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • RHS Financial held 1,229 shares of Jazz Pharmaceuticals worth $296K as of Q2 2026.
  • RHS Financial bought 153 Jazz Pharmaceuticals shares in Q2 2026, an estimated $33.5K.
  • Jazz Pharmaceuticals made up 0.12% of RHS Financial's portfolio in Q2 2026, its #131 holding.
  • RHS Financial first reported a position in Jazz Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 396 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on RHS Financial's 13F filing for Q2 2026, filed 7 Aug 2026.